The weekly litigation news digest is live. Subscribe now
The patent EP3663890 was granted to Genemind Biosciences on Apr 10, 2024. The application was originally filed on Aug 2, 2017 under application number EP17919940A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
A sequence alignment method that improves sensitivity and accuracy by converting reads into short fragments and converting sequence information into position information. The method aligns short fragments with a reference library constructed from a reference sequence, removes fragments positioned on adjacent entries, and extends the alignment based on the remaining fragments. The method is particularly suitable for aligning reads containing unrecognized bases, such as those with gaps or N bases.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent citations refer to prior patents cited during different phases such as opposition or international search.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents